These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 7863872)
1. Hypercoagulability and the hypercoagulability syndromes. Perler BA AJR Am J Roentgenol; 1995 Mar; 164(3):559-64. PubMed ID: 7863872 [TBL] [Abstract][Full Text] [Related]
2. The investigation of a heart valve patient with suspected hypercoagulability. Gough SC; Prentice CR J Heart Valve Dis; 1993 Jan; 2(1):7-17. PubMed ID: 8269113 [TBL] [Abstract][Full Text] [Related]
3. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients. Jespersen J Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796 [TBL] [Abstract][Full Text] [Related]
4. Thrombophilia and hypercoagulability. Hassouna HI Med Princ Pract; 2009; 18(6):429-40. PubMed ID: 19797918 [TBL] [Abstract][Full Text] [Related]
5. Blood viscosity and thrombosis: clinical considerations. Smith BD; La Celle PL Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612 [TBL] [Abstract][Full Text] [Related]
12. Impact of automation on the quantitation of low molecular weight markers of hemostatic defects. Fareed J; Walenga JM; Bick RL; Bermes EJ; Messmore HL Semin Thromb Hemost; 1983 Oct; 9(4):355-79. PubMed ID: 6229030 [TBL] [Abstract][Full Text] [Related]
13. Pro-thrombotic states and their diagnosis. Coccheri S; Palareti G Ann Ital Med Int; 1994; 9(1):16-21. PubMed ID: 8003387 [TBL] [Abstract][Full Text] [Related]
14. The association between blood coagulation markers, atherothrombosis and dementia. Gupta A; Pansari K Int J Clin Pract; 2003 Mar; 57(2):107-11. PubMed ID: 12661793 [TBL] [Abstract][Full Text] [Related]
15. [Blood coagulation changes and neoplastic pathology]. Corsi MP; De Martinis M; Di Leonardo G; Loreto MF; Modesti M; Quaglino D Recenti Prog Med; 2000 Oct; 91(10):532-7. PubMed ID: 11072743 [TBL] [Abstract][Full Text] [Related]
16. [Thrombophilia, prethrombotic conditions, hypercoagulability]. Rolović Z Srp Arh Celok Lek; 1997; 125(3-4):69-74. PubMed ID: 9221521 [TBL] [Abstract][Full Text] [Related]
17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
18. Thyroid disorders and hypercoagulability. Erem C Semin Thromb Hemost; 2011 Feb; 37(1):17-26. PubMed ID: 21249601 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of recurrent thrombosis and hypercoagulability. Harris JM; Abramson N Am Fam Physician; 1997 Oct; 56(6):1591-6, 1601-2. PubMed ID: 9351428 [TBL] [Abstract][Full Text] [Related]
20. Clotting mechanisms and cancer: implications in thrombus formation and tumor progression. Falanga A; Marchetti M; Vignoli A; Balducci D Clin Adv Hematol Oncol; 2003 Nov; 1(11):673-8. PubMed ID: 16258469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]